BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4397134)

  • 1. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 4. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetics of audiogenic seizures. 3. Time response relationships between drug administration and seizure susceptibility.
    Schlesinger K; Boggan WO; Freedman DX
    Life Sci I; 1970 Jul; 9(13):721-9. PubMed ID: 4394568
    [No Abstract]   [Full Text] [Related]  

  • 6. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 7. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 9. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral amines and acute hyperbaric oxygen toxicity.
    Blenkarn GD; Schanberg SM; Saltzman HA
    J Pharmacol Exp Ther; 1969 Apr; 166(2):346-53. PubMed ID: 5776990
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of melipramine on carbohydrate and monoamine metabolism in the brain of reserpinized rats].
    Goncharova EE; Kocherga VI; Chugai GN
    Ukr Biokhim Zh; 1972; 44(2):154-9. PubMed ID: 4661059
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
    Johnson GA; Kim EG; Boukma SJ
    J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of dehydroepiandrosterone on aggressive behaviour.
    Paroli E; Pantaleoni GC; Valeri P; Nencini P; Jame R
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():S 196:147-. PubMed ID: 4262236
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of brain norepinephrine in audiogenic seizure in the rat.
    Jobe PC; Picchioni AL; Chin L
    J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
    [No Abstract]   [Full Text] [Related]  

  • 19. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 20. The interrelation of hypothermia and depletion of noradrenaline, dopamine and 5-hydroxytryptamine from brain by reserpine, para-chlorophenylalanine and alpha-methylmetatyrosine.
    Somerville AR; Whittle BA
    Br J Pharmacol Chemother; 1967 Sep; 31(1):120-31. PubMed ID: 6055247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.